Indication
Recurrent oropharyngeal carcinoma
1 clinical trial
1 drug
Clinical trial
RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled TrialStatus: , Estimated PCD: 2024-10-12
Drug
Celecoxib